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ABSTRACT
Background and aims: inflammatory bowel disease devel-
opment has been associated with several environmental 
factors, among which, diet can play a key role, probably due 
to a westernized lifestyle. However, its involvement in the 
pathogenesis of inflammatory bowel disease (IBD) is diffi-
cult to demonstrate. The aim of this study was to analyze 
dietary composition in a Romanian and Belgian population 
with IBD.
Methods: an observational retrospective comparative study 
was performed using two European cohorts (Romanian and 
Belgian). The IBD group included 76 Romanian and 53 Bel-
gian patients with an IBD diagnosis, while the control group 
included a total of 56 healthy people (35 Romanians and 21 
Belgians). All subjects were interviewed and asked to fill in 
a questionnaire regarding diet. 
Results: in the entire IBD cohort (Romanian + Belgian), a sig-
nificantly increased consumption of sweets (OR 3.36 [95 % 
CI 1.6,7]), processed and high fat meat (OR 2.5 [95 % CI 1.4, 
4.7], fried food (OR 9.5 [3.8, 23.6]), salt (OR 2.8 [1.5, 5.3]), ice 
cream (OR 3.25 [1.1, 9.8]), mayonnaise (OR 3.49 [1.1, 10.3]), 
margarine (OR 5.63 [1.64, 19.33]) and chips/nachos/other 
snacks (OR 2.3 [0.97, 5.73]) were found compared to the 
healthy control group. The intake of seeds, nuts (OR 0.26 
[0.14, 0.52]) and yoghurt consumption (OR 0.44 [0.23, 0.83]) 
was lower in the IBD group compared to the control group. 
Conclusion: a westernized diet with increased consumption 
of sweets, processed food, high fat meat, fried food, salt, 
margarine, snacks, ice cream and mayonnaise seems to be 
a risk factor for IBD in Romanian and Belgian IBD patients. 
Intake of seeds, nuts and yoghurt may be a protective factor.
Keywords: Inflammatory bowel diseases. Crohn’s disease. 
Ulcerative colitis. Diet.
BACKGROUND AND AIMS
Inflammatory bowel diseases (IBD), mainly Crohn’s disease 
(CD) and ulcerative colitis (UC), are chronic inflammato-
ry conditions of the gastrointestinal tract. The interaction 
between environmental factors and normal intestinal 
commensal microbiota in IBD patients can lead to an inap-
propriate immune response that results in chronic inflam-
mation (1,2). 
IBD was primarily recognized in westernized countries fol-
lowing the rise of the industrial revolution. The incidence 
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of IBD dramatically increased during the 20th century with 
a significant prevalence in developed nations such as Cana-
da, the United States and Western Europe (3). As individuals 
move from areas of low to high prevalence, first-generation 
offspring acquire the same risk of developing IBD as the 
local population (4). This shift in risk suggests that changes 
in environment, in addition to genetic predisposition, con-
tribute to the development of IBD.
Several environmental factors have been associated 
with IBD, such as smoking, hygiene, microorganisms, 
oral contraceptive pills, non-steroid anti-inflammatory 
drugs, antibiotics, appendectomy, diet, breastfeeding, 
vitamin D, stress and ambient air pollution (5). Howev-
er, a clear mechanism by which these environmental risk 
factors interact to cause IBD has not been elucidated (5). 
Furthermore, most risk factors have not been consistent-
ly demonstrated across different studies. A low-fiber, 
high-carbohydrate and fat-rich diet seems to play a role in 
the development of IBD via mechanisms related to insulin 
resistance, alteration of intestinal permeability, stimula-
tion of proinflammatory pathways and the generation of 
dysbiosis (8,9). The prospective ECCO-EpiCom study of 
patients with IBD in 31 European countries has shown a 
higher number of western-associated risk factors in East-
ern Europe, including high-sugar and low-fiber diets (8). 
Belgium has a high incidence of IBD. A study published 
in 1998 reported a mean annual incidence per 10(5) of 4.5 
for CD and 3.6 for UC, while in Romania the incidence of 
IBD is much lower, 0.5 per 10(5) for CD and 0.97 per 10(5) 
for UC (6,7).
The aim of this project was to analyze dietary composition 
and patterns in a retrospective comparative Romanian-Bel-
gian study, enrolling 2 groups of patients with inflammatory 
bowel disease (IBD). 
METHODS
Type of study
An observational retrospective case-control study was per-
formed using two cohorts, one from Romania and one from 
Belgium. 
Patients
All IBD patients admitted to the Gastroenterology Outpa-
tient Unit of the Fundeni Clinical Institute and Centre Hos-
pitalier Universitaire de Liege during October 2017 were 
selected, with a total number of 76 and 53 subjects, respec-
tively. The inclusion criteria for these groups were age over 
18 years and disease duration over 6 months (from IBD 
diagnosis). The exclusion criteria were concurrent Clostrid-
ium difficile or CMV colitis, total suppression of oral intake 
and exclusive parenteral/enteral nutrition.
Control groups
The control groups included 35 Romanian and 21 Belgian 
healthy subjects, 50 % were recruited from hospital employ-
ees and 50 % were referred by general practitioners near 
the hospital. The control group was similar to the individu-
als from the case group in terms of age and sex distribution. 
All subjects were interviewed and asked to fill in a ques-
tionnaire regarding current and past diet preferences (diet 
before disease onset was recorded) (Fig. 1). A member of 
our team oversaw the process and the informed consent 
was signed by all subjects before enrollment. 
Variables
Figure 1 shows the data recorded for every subject: age, 
sex, type of disease (ulcerative colitis/Crohn’s disease), 
disease classification according to Montreal classification 
and disease severity (i.e. severity of the first flare, the most 
severe flare and the actual score of severity). The CDAI 
score was used for Crohn’s disease and the Mayo score 
for ulcerative colitis.
Variables regarding diet before disease onset were regis-
tered as follows: number of daily portions of vegetables, 
fruits and high grain cereals, number of weekly portions 
of fish, processed meat, seeds and nuts. The frequency of 
intake of the following foods was noted from daily to rare: 
cheese, yogurt, fruit yogurt, butter, high fat meat, marga-
rine, fried foods, commercial ice-cream, mayonnaise and 
chips/nachos/other snacks. Sugar-sweetened beverage con-
sumption was reported from less than 1 liter /day to more 
than 1 liter/day while sweets consumption was rated as 
rare, occasional or frequent (daily). 
Statistical analysis
Data analysis was performed using the SPSS statistical 
software (20.0 version from IBM Corporation, Armonk, NY, 
USA). The quantitative variables with a non-parametric 
distribution were summarized as the median with mini-
mum and maximum values and were compared using the 
Mann-Whitney U test. Categorical variables were summa-
rized as percentages and compared using the Fisher’s exact 
test. Two-sided hypothesis testing was used and a p value 
of less than 0.05 was considered as statistically significant. 
A logistic regression model was built with the presence 
of inflammatory bowel disease as a dependent variable 
and risk factors associated with a p < 0.10 according to the 
bivariate analysis as independent variables. The regression 
analysis was performed in a stepwise forward manner, due 
to the relatively small sample compared to the number of 
variables.
The sample size was calculated for an alpha error of 5 % 
and a statistical power of 80 % to detect an odds ratio of 
at least 3. This considered the risk factor with the closest 
prevalence to 50 % in the general population, which was 
62 % (daily sugar consumption from the Romanian National 
Institute of Public Health) (10). The estimated sample size 
was 116 patients in the study group and 58 in the control 
group, calculated with WinPepi 11.65 (11).
The Ethics Committees of the institutions involved approved 
the study and a grant offered by the Romanian Executive 
Unity for Financing and Supporting of Higher Education 
(UEFISCDI): 112 BM supported the study.
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The analysis of diet in patient with non-specific inflammatory bowel disese
1. General information about the patient
 Name and surname-initials ...............................            Age ............................................
 Sex: M  / F          Address: urban  / rural 
2. Medical information about the patient
 Disease diagnosis (according to Monreal classification – including extraintestinal manifestations ..................................................................  
 ................................................................................................................................................................................................................................................
 The year of diagnosis ..........................................................................................................................................................................................................
 First flare severity: – Crohn´s disease (CDAI) ............... points
  – Ulcerative colitis (Mayo score) ............... points
 Severity score of the most severe flare ..............................
 Actual score of severity ..............................
3. Information regarding patients lifestyle before IBD. Nutrition
Type of food Number of portions / day Observations
Vegetables-fruits > 4 portions < 4 portions
Fish consumption > 2 portions/week < 2 portions/week
Salt consumption Very low High/moderate
Sweets and sweetened beverages
< 11 sweetened beverages 
with sugars
Occasional





(3 slices of bread)
< 3 portions/day
(3 slices of bread)
Seeds and nuts consumption
1 portion = a handful
> 4 portions/week < 4 portions/week
Processed meat < 2 portions/week > 2 portions/week
Cheese (cottage cheese, semi-hard yellow cheese) Daily Rare
Yogurt Daily Rare
Fruit yogurt Daily Rare
Butter Daily Rare


















*1 portion of vegetables = 1 cup of chopped raw vegetables or ½ of cup of boiled vegetables + 1 small tomatoes + 1 small cucumber.
**1 portion of fruits = 1 small apple, 1 peach, 1 small orange, one kiwi, a handful of strawberries or cherries.
Fig. 1. Questionnaire. Environmental factors in patients with inflammatory bowel disease.
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the median age was 42 years in the IBD group and 49 years 
in the control group, with a similar and relatively equal sex 
distribution (52.6 % men vs. 47.6 %, p = 0.7). 
Analysis of dietary factors
Comparison between the Romanian IBD cohort and 
control group
Concerning diet composition, several differences were 
noted in the Romanian IBD group. In the IBD group, there 
was a significantly higher consumption of salt (89.5 % vs. 
52.4 %, p < 0.001), sweets and sweetened beverages (50 % 
vs. 14.30 %, p < 0.001), processed meat (63.2 % vs. 28.6 %, 
p < 0.001), high fat meat (52.6 % vs. 19 %, p < 0.001) and 
fried foods (60.5 % vs. 4.8 %, p < 0.001) compared to the 
control group. Conversely, there was a significantly low-
er intake of seeds and nuts and yogurt in the Romanian 
IBD patients compared to the healthy subjects (15.8 % vs. 
52.4 %, p < 0.001; 26.3 % vs. 47.6 %, p = 0.026). The results 
were at the limit of statistical significance for fruit yogurt 
(0 % vs.4.8 %, p = 0.056). There were no statistically sig-
nificant differences between the two analyzed groups in 
terms of the consumption of vegetables-fruits, fish, high 
grain cereals, cheese, butter, margarine, commercial ice 
cream, commercial mayonnaise and chips/nachos/other 
snacks (Fig. 2). 
Comparison between the Belgian IBD cohort and control 
group
In the Belgian cohort, the results indicated a significantly 
lower percentage of subjects who consumed vegetables 
and fruits in the IBD group compared to the control group 
(30.2 % vs. 59.1 %, p = 0.019). Although, a higher percent-
age was obtained in the case of margarine consumption 
(45.3 % vs. 13.6 %, p = 0.009). Regarding other foods, the 
consumption did not differ significantly in the IBD and 
control group in terms of fish, salt, sweets and sweetened 
RESULTS
Description of the case-control groups
Romanian IBD group
Males were more frequent in this group (52.6 %), the medi-
an age was 41 years, CD was more predominant (60.5 %) 
and the median IBD duration was 5 years. CD patients had 
a median age of 42, a slight predominance of female sex 
and a median disease duration of 3 years. Age at onset 
was more frequent between 17 and 40 years, the ileocolon-
ic location and the B1 phenotype was the most prevalent; 
13 % had perianal disease (Table 1). Romanian UC patients 
had a median age of 41, with a slight male predominance 
(66.7 %), a median disease duration of 6 years and the left 
colonic location was more frequent (53.3 %) (Table 1).
Belgian IBD group
The median age in this group was 42 years, females were 
predominant (approx. 70 %), CD was more frequent (cca. 
80 %) and the median disease duration was 11 years. Bel-
gian CD patients had a median age of 42 years, were pre-
dominantly female (approx. 70 %), with a median extent of 
disease of 10 years. The A1 phenotype was more prevalent 
(according to Montreal classification), while the ileocolonic 
location (L1) and B1 phenotype were the most frequent. 
40 % of the patients had perianal disease. The median age 
of Belgian UC cases was 43.5 years, 80 % were female and 
78 % had left colonic disease extension.
Comparison between study groups and control groups
IBD patients in both the Romanian and Belgian populations 
were matched by age and gender with the control cohort. 
Belgian subjects had a median age of 42 years and a female 
predominance in both groups. In the Romanian population, 
Table 1. A comparison between Romanian and Belgian patients: general characteristics
Variable Romanian CD patients (n = 46) Belgian CD patients (n = 43) p
Males (%) 43.5 % 32.6% 0.383
Median age (min. ÷ max.) 42 years (19 ÷ 67 years) 42 years (19 ÷ 73 years) 0.183
Median disease duration 3 years (0.5 ÷ 14 years) 10 years (1 ÷ 42 years) < 0.001
A1/A2/A3 0/73.9/26.1 % 15/75/10 % 0.005
L1/L2/L3 26.1/34.8/39.1 % 30/12.5/57.5 % 0.335
B1/B2/B3 45.4/27.3/27.3 % 60/20/20 % 0.208
Upper GI tract location (L4) 4.3 % 11.4 % 0.231
Perianal disease 13 % 40 % 0.006
Variable Romanian UC patients (n = 30) Belgian UC patients (n = 10) p
Males (%) 66.7 % 20 % 0.025
Median age (min. ÷ max.) 41 years (28 ÷ 74 years) 43.5 years (26 ÷ 64 years) 0.569
Median disease duration 6 years (0.5 ÷ 15 years) 11.5 years (1 ÷ 16 years) 0.158
E1/E2/E3 6.7/53.3/40 % 0/77.8/22.2 % 0.588
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beverages, high grain cereals, seeds and nuts, processed 
meat, cheese, yogurt, fruit yoghurt, butter, high fat meat, 
fried foods, ice cream, mayonnaise and chips/nachos/other 
snacks. (Fig. 3). 
Comparison between the IBD cohort (Romanian + 
Belgian) and control group
Table 2 shows the results of the bivariate analysis con-
cerning the impact of different dietary factors in patients 
with inflammatory bowel diseases. Daily fried foods were 
the most potent factors associated with IBD, followed by 
excessive consumption of sweets, margarine, processed 
meat, commercial ice cream, mayonnaise or dressings and 
increased salt intake. An adequate amount of seeds and 
nuts and yogurt consumption were important dietary pro-
tective factors.
All dietary variables were introduced in the logistic regres-
sion model that were associated with IBD (p < 0.10). Two 
variables remained in the model as independently associat-
ed with IBD (Table 3); excessive salt consumption and pro-
cessed meat. All other variables which were significantly 
associated with IBD in the bivariate analysis (Table 2) were 
not maintained in the regression model. 
Fig. 3. Food types and consumption levels in Belgian patients with IBD prior to disease onset versus healthy 
controls (according to questionnaires) (IBD: inflammatory bowel disease; pt: portion; d: day; w: week).
Fig. 2. Food types and consumption levels in Romanian patients with IBD prior to disease onset versus healthy 
controls (according to questionnaires) (IBD: inflammatory bowel disease; pt: portion; d: day; w: week).
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The rising incidence of IBD in Eastern Europe is thought 
to be a result of westernized living Therefore, this study 
aimed to perform a diet analysis between a Romanian and 
a Belgian IBD population. 
An essential environmental factor identified in our study 
was in relation to vegetable and fruit consumption, which 
was higher in the Belgian control group compared to the 
IBD group. 59.1 % of healthy subjects reported consuming 
at least 4 servings per week, while this was 30.2 % in IBD 
patients. Many other studies have also shown that eating 
vegetables and fruits, which are high fiber foods, can be 
a protective factor for the development of IBD (12-14). A 
similar study to this one performed in a western population 
(Denmark) has shown that the daily intake of vegetables 
was associated with a low risk of developing both Crohn’s 
disease and ulcerative colitis (OR = 0.41, 95 % CI: 0.24-0.71 
and OR = 0.51, 95 % CI: 0.31-0.84, respectively) (13).
High grain cereal consumption did not differ between IBD 
and control groups in either of the populations; Roma-
nian and Belgian was 53.8 % vs. 50 % and 52.6 % vs. 33 %, 
respectively. Interestingly, a high consumption of seeds and 
nuts in the Romanian IBD group was approximately three 
times lower than that of the control group. Other studies 
have shown significant beneficial effects of fiber consump-
tion only for ulcerative colitis (15,16). These results for 
ulcerative colitis are maintained in one pediatric population 
in a Danish study (OR = 0.3, CI: 0.1-0.8) (17).
The EpiCom cohort was a population-based, prospective 
inception cohort of 1182 IBD patients from 31 European 
countries (444 CD, 627 UC, 111 IBD unclassified). Patients 
were asked to complete an 87-item questionnaire at diag-
nosis about environmental factors. Sugar intake was higher 
in CD and UC patients from Eastern Europe than in Western 
Europe, whereas fiber intake was lower (p < 0.01). Daily 
consumption of fast food was more frequent in Eastern 
European than in Western European UC patients (p < 0.01) 
(19). These results are consistent with the findings obtained 
in the Romanian cohort and also with the results of a bivar-
iate analysis performed of the entire group of IBD patients 
(Romanian + Belgian). 
With regard to dairy products, Romanian healthy subjects 
had a higher yogurt consumption compared to those with 
IBD. The 47.6 % of patients in the control group ate yogurt 
daily compared to 26.3 % in the IBD group and there were 
no differences in the consumption of either cheese or but-
ter. The two groups were similar in the Belgian cohort with 
respect to this food category. The potential protective effect 
of yogurt against the onset of IBD was highlighted in our 
study by the results of bivariate analysis that included both 
Romanian and Belgian patients (OR 0.44 [95 % CI: 0.23, 
0.83, p = 0.014]). Yogurt could have beneficial effects in 
IBD due to its probiotic content, causing an increase in the 
number of probiotic bacteria in the colon on one hand and 
balancing an excess of anti-inflammatory molecules from 
detrimental to pro-inflammatory ones on the other hand 
(20-24). Dairy consumption (milk, cheese, yoghurt) was also 
analyzed in the EPIC study. The results showed that individ-
Table 2. A comparison of diet composition in IBD patients (Romanian and Belgian) and the control group (bivariate 
analysis)
Variable




p OR (95 % CI)
Moderate-high salt amount 76 % 53.1 % 0.002 2.8 [1.5. 5.3]
Sweets/sweetened drinks > 1 L/day 41.1 % 17.2 % 0.001 3.36 [1.6. 7]
Seeds/nuts (> 4 pt/week) 17.1 % 43.8 % < 0.001 0.26 [0.14.0.52]
Processed meat (> 2 pt/week) 63.3 % 40.6 % 0.003 2.5 [1.4. 4.7]
Daily high fat meat 51.9 % 28.1 % 0.002 2.76 [1.45. 5.26]
Daily yogurt 25.6 % 43.8 % 0.014 0.44 [0.23. 0.83]
Daily margarine 21.7 % 4.7 % 0.002 5.63 [1.64. 19.33]
Daily fried foods 49.6 % 9.4 % < 0.001 9.5 [3.8. 23.6]
Daily ice-cream 17.8 % 6.2 % 0.029 3.25 [1.1. 9.8]
Daily mayonnaise 18.6 % 6.2 % 0.028 3.49 [1.1. 10.3]
Daily chips/nachos/other snacks 22.5 % 10.9 % 0.053 2.3 [0.97. 5.73]
Table 3. Multivariable analysis (logistic regression) with IBD as dependent variable
Variable Coefficient p OR (95 % CI)
Moderate-high salt amount 1.516 0.010 4.55 [1.44, 14.4]
Processed meat (> 2 pt/week) 2.117 < 0.001 8.3 [2.6, 26.7]
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uals who consumed milk have a lower risk of developing 
Crohn’s disease (not ulcerative colitis) than those who do 
not consume any (OR: 0.3, 95 % CI: 0.13-0.65), there were 
no significant correlations for the other products (25).
Our study also indicates that the consumption of high-fat 
meat was higher in the Romanian IBD group compared to 
the control group (52.6 % vs. 19 %), but not in the Bel-
gian cohort (50.9 % vs. 45.5 %). This finding was confirmed 
via the bivariate analysis performed in the whole group 
(OR 2.76 [1.45, 5.26] (p = 0.002)). Red meat is associated 
with the risk of IBD due to the metabolism of linoleic acid 
content that leads to the generation of leukotrienes and 
prostaglandins (pro-inflammatory mediators) (12,18,26). A 
meta-analysis of nine studies published in 2015, reported 
a significantly higher risk of IBD for meat consumers than 
those who did not consume meat at all or in small amounts 
(pooled RR: 1.5, 95 % CI: 1.15-1.95) (27). 
If the consumption of high fat meat was higher in the 
Romanian IBD group and in the entire group of IBD 
patients, no differences were found in any of the cohorts 
(Romanian and Belgian) in terms of fish consumption. 
However, as indicated by two recently published systemat-
ic reviews, there are numerous studies that found fish con-
sumption to be a protective factor for the development of 
IBD, including pediatric populations (12,28). These results 
contradict the initial findings and could be explained by 
the increased content of ω-6 PUFA with pro-inflammatory 
effects in red meat and ω-3 PUFA with anti-inflammatory 
effects in fish. Although this mechanism has not been fully 
demonstrated (12,28,29).
Furthermore, there was a significantly higher consumption 
of processed meat in the IBD group in the Romanian cohort 
compared to the control group (89.5 % vs. 52.4 %). This 
finding was confirmed in the bivariate analysis (OR 2.5 [1.4, 
4.7]; p = 0.003) and the multivariable analysis (OR 8.3 [2.6, 
26.7]; p < 0.001). Processed meat is rich in food additives, 
such as detergent-like molecules. This can interfere with 
barrier function in the gut and also modify intestinal micro-
biota, which consequently promotes inflammation (30,31). 
Besides processed meats, other foods such as margarine, 
commercial mayonnaise, ice cream, chips and related prod-
ucts are known for their content of food additives. In our 
study, there were significant differences reported in the 
Belgian cohort and in the entire IBD cohort (Romanians 
+ Belgians). The 43.5 % of Belgian IBD patients used to 
consume margarine daily compared to 13.6 % of individu-
als from the control group, 21.7 % in the entire IBD group 
versus 4.7 % in the entire healthy control group (OR 5.63 
[95 % CI 1.64, 19.33]). Similarly, Maconni et al. showed a 
significantly higher risk of UC for a moderate consumption 
(OR: 11.8, CI: 1.51-91.99) compared to a high consumption 
(OR: 21.37, CI: 2.32-196.6) of margarine, which was not sta-
tistically significant for CD (24). 
The literature suggests that monosaccharide and sweets 
intake have a negative effect on IBD. Our study also con-
firmed a higher consumption of sweets and sweetened 
beverages by Romanian IBD patients before disease onset 
compared to the healthy people. The bivariate analysis was 
performed on the entire cohort of patients with IBD ver-
sus healthy volunteers and showed an OR of 3.36 ([95 % 
CI 1.6, 7], p = 0.001) (13,32). Supporting our findings, the 
EPIC prospective study demonstrated a positive association 
between sweeteners and soft drinks and ulcerative colitis. 
The risk was even higher when associated with a lower 
vegetables consumption (33). A recent meta-analysis of 
1361 IBD cases did not find an association between the high 
dietary total carbohydrate intake and UC or CD (OR 1.167 
(0.777-1.752) and 1.010 (0.630-1.618), respectively). How-
ever, this meta-analysis included only studies from Europe 
and Asia, with a substantial heterogeneity (34).
In the Romanian cohort and in the entire IBD cohort, the 
consumption of fried food and salt was significantly higher 
in the IBD group compared to the control group (OR 9.5 and 
2.8, respectively). This was also confirmed in the multivar-
iate analysis of a moderate-high diet salt level. Both the 
above-mentioned foods and fried foods have an increased 
content of trans-unsaturated fatty acids, which appear to 
be associated with the occurrence of UC in cases of long-
term intake (35).
The focal point of this original study is the use two cohorts 
from Eastern and Western Europe and a parallel analysis of 
diet via a detailed questionnaire that thoroughly assessed 
the alimentary habits of each subject. One limitation of this 
study was the relatively low number of subjects included; 
111 in the Romanian cohort and 74 in the Belgian cohort. 
Even though statistical power was reached with our data. 
Another limitation of the study is control group compo-
sition, which was partially selected from healthy hospital 
employees and 50 % were referred by general practitioners 
near to the hospital. However, this may not represent the 
general population and further studies should be performed 
in multinational cohorts.
CONCLUSION
The results obtained in this study reflect significant dif-
ferences in dietary patterns of people with IBD versus the 
healthy population. The consumption of sweets and sweet-
ened beverages, processed and high fat meat, fried food, 
salt, bought from shop ice cream and mayonnaise was 
higher in the entire IBD cohort than in the healthy control 
group. Whereas seeds, nuts and yoghurt consumption was 
lower. These differences in diet may provide a clue to the 
possible environmental factors involved in the develop-
ment of intestinal inflammatory diseases.
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